Sutured protective occluder for severe amblyopia

Archives of Ophthalmology

Volumn 126, Issue 7, 2008, Pages 891-895

  Arnold, Robert W ^a   Armitage, Mary Diane ^a   Limstrom, Scott A ^b  

^a Ophthalmic Associates   (United States)

^b Alaska Retinal Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBLYOPIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEVICE; EYE PROTECTION; FEMALE; HUMAN; MALE; OCCLUSIVE DRESSING; ORBIT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REFRACTION ERROR; SKIN SCAR; STRABISMUS; SUTURING METHOD; TREATMENT OUTCOME; VISUAL ACUITY;

AMBLYOPIA; BIOCOMPATIBLE MATERIALS; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; OPHTHALMOLOGIC SURGICAL PROCEDURES; OPHTHALMOLOGY; POLYMERS; POLYPROPYLENES; SENSORY DEPRIVATION; SUTURE TECHNIQUES; SUTURES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 47549095206     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.7.891     Document Type: Article

References (38)

1. Woodruff G, Hiscox F, Thompson JR, Smith LK. Factors affecting the outcome of children treated for amblyopia. Eye. 1994;8(pt 6):627-631.
2. Newsham D. Parental non-concordance with occlusion therapy. Br J Ophthalmol. 2000;84(9):957-962.
3. Oliver M, Neumann R, Chaimovitch Y. Gotesman N, Shimshoni M. Compliance and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol. 1986;102(3)340-345.
4. Simons K, Preslan M. Natural history of amblyopia untreated owing to lack of compliance. Br J Ophthalmol. 1999;83(5):582-587.
5. Searle A. Norman P, Harrad R, Vedhara K. Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children. Eye. 2002;16(2):150-155.
6. Mazow ML, Chuang A, Vital MC, Prager T. 1999 Costenbader tecture: outcome study in amblyopia: treatment and practice pattern variations. J AAPOS. 2000;4(1):1-9.
7. Cleary M. Efficacy of occlusion for strabismic amblyopia; can an optimal duration be identified? Br J Ophthalmol. 2000;84(6):572-578.
8. Cotter SA, Edwards AR, Wallace DK, et al; Pediatric Eye Disease Investigator Group. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology. 2006;113(6):895-903.
9. Foley-Nolan A, McCann A. O'Keefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br J Ophthalmol. 1997;81(1):54-57.
10. France TD, France LW. Optical penalization can improve vision after occlusion treatment. J AAPOS. 1999;3(6):341-343.
11. Clorfeine GS, Parker WT. Use of a transparent film dressing to enhance compliance with occlusion therapy for amblyopia. Am J Ophthalmol. 1992;114(2):229-230.
12. Rubab S, French D, Levin AV. Glued patches for children resistant to amblyopia occlusion therapy. Arch Ophthalmol. 2008;126(1):133-134.
13. Dorey SE. Adams GG, Lee JP.SIoperJJ. Intensive occlusion therapy for amblyopia. Br J Ophthalmol. 2001;85(3):310-313.
14. Eustis HS, Chamberlain D. Treatment for amblyopia: results using occlusive contact lens. J Pediatr Ophthalmol Strabismus. 1996;33(6):319-322.
15. Burger DS. tondon R. Soft opague contact lenses in binocular vision problems. J Am Optom Assoc. 1993;84(3):176-180.
16. Joslin CE. McMahon TT. Kaufman LM. The effectiveness of occluder contact lenses in improving occlusion compliance in patients that have failed traditional occlusion therapy. Optom Vis Sci. 2002;79(6):376-380.
17. Tsubota K, Yamada M. Treatment of amblyopia by extended-wear occlusion soft contact lenses. Ophthalmologica. 1994;208(4):214-215.
18. Elder MJ. Occlusion therapy for strabismic amblyopia. Aust N Z J Ophthalmol. 1994;22(3):187-191.
19. Kitchens J. Kinder J. Getting T. The drawstring temporary tarsorrhaphy teehnique. Arch Ophthalmol. 2002;120(2):187-190.
20. Donnenfeld ED, Perry HD, Nelson DB. Cyanoacrylate temporary tarsorrhaphy in the management of corneal epithelial defects. Ophthalmic Surg. 1991;22(10):591-593.
21. Kirkness CM. Adams GG. Dilly PN. Lee JP. Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology. 1988;95(4):473-480.
22. Halkiadakis I, lliaki O, Kalyvianaki M.Tsilimbaris M. Occlusion therapy of unilateral amblyopia with botulinum toxin induced ptosis. Semin Ophthalmol. 2007;22(1):55-57.
23. Moseley MJ, Fielder AR. Measurement of compliances with occlusion therapy. J Pediatr Ophthalmiol Strabismus. 1995;32(6):399-400.
24. Fielder AR, Irwin M, Auld R, Cocker KD, Jones HS, Moseley MJ. Compliance in amblyopia therapy: objective monitoring of occlusion. Br J Ophthalmol. 1995;79(6):585-589.
25. Fielder AR. Electronic monitoring of treatment compliance in patching for amblyopia. Surv Ophthalmol. 2000;44(6):539-540.
26. Hiscox F, Strong N, Thompson JR. Minshull C, Woodruff G. Occlusion for amblyopia: a comprehensive survey of outcome. Eye. 1992;6(pt 3):300-304.
27. Bhola R, Keech RV, Kutschke P, Pfeifer W, Scott WE. Recurrence of amblyopia after occlusion therapy. Ophthalmology. 2006;113(11):2097-2100.
28. Wu C, Hunter DG. Amblyopia: diagnostic and therapeutic options. Am J Ophthalmol. 2006;141(1);175-184.
29. Rosner J, Rosner J. Parents as screeners for strabismus in their children. J Vis Impair Blindness. 1988;82(6):193-194.
30. Committee on Practice and Ambulatory Medicine and Section on Ophthalmology, American Academy of Pediatrics. Use of photoscreening for children's vision screening. Pediatrics. 2002;109(3):524-525.
31. Donahue SP. Relationship between anisometropia, patient age, and the development of amblyopia. Am J Ophthalmol. 2006;142(1):132-140.
32. Mohan K, Saroha V, Sharma A. Successful occlusion therapy for amblyopia in 11-to 15-year-old children. J Pediatr Ophthalmol Strabismus. 2004;41(2):89-95.
33. Scheiman MM, Hertle RW, Beck RW, et al; Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005;123(4):437-447.
34. Mayers LB, Judelson DA, Moriarty BW, Rundell KW. Prevalence of body art (body piercing and tattooing) in university undergraduates and incidence of medical complications. Mayo Clin Proc. 2002;77(1):29-34.
35. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120(3):268-278.
36. Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia and other factors. Ophthalmology. 2003;110(8):1632- 1638.
37. Holmes JM, Kraker RT, Beck RW, et al; Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003;110(11):2075-2087.
38. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with patching in children: experience of the Amblyopia Treatment Study. Am J Ophthalmol. 2003;136(4):620-629.